Price
No data yet.
Social Signal Score
Analyst Ratings
15 analystsRevenue
$166.80M-31.39%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Jeffrey S. Niew
- Sector
- Technology
- Industry
- Hardware, Equipment & Parts
- Employees
- 5,200
- Beta
- 1.59
- Country
- US
- Piotroski score
- 8 / 9 (Strong)
- Altman Z-score
- 7.41
Financials
Revenue
$166.80M-31.4%Net Income
$19.40M+7.8%EBITDA
$34.60M-19.5%Free Cash Flow
$21.70M+29.2%EPS (diluted)
$0.22+10.0%Shares Outstanding (diluted)
87.90M-1.6%Operating Expenses
$45.80MCash & Debt
$49.60MReturn of Capital
$15.00MRevenue by Segment (annual)
$593.20MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $593.20M | $44.20M | $0.51 |
| 2024 | $553.50M | $-239.50M | $-2.69 |
| 2023 | $456.80M | $72.40M | $0.80 |
| 2022 | $478.80M | $-430.10M | $-4.69 |
| 2021 | $868.10M | $150.40M | $1.63 |
| 2020 | $764.30M | $6.60M | $0.03 |
| 2019 | $854.80M | $49.10M | $0.54 |
| 2018 | $826.90M | $66.10M | $0.75 |
| 2017 | $744.20M | $6.00M | $0.76 |
| 2016 | $755.70M | $-16.70M | $-0.48 |
| 2015 | $849.60M | $-233.80M | $-2.69 |
| 2014 | $1.14B | $-87.00M | $-1.02 |
| 2013 | $1.21B | $105.81M | $1.24 |
| 2012 | $1.12B | $79.10M | $0.93 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from KN's reported EPS growth of -4.5% a year over 13 years.
- EPS in 5 years
- $0.41
- Implied price
- $17.19
- Return from $40.05
- -15.6% a year
To earn 15.0% a year on these assumptions you'd need to buy at $8.54 — -78.7% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 30 | 36 | 42 | 48 | 54 |
|---|---|---|---|---|---|
| -14.5% | -29.3% | -26.7% | -24.4% | -22.4% | -20.5% |
| -9.5% | -25.2% | -22.4% | -20.0% | -17.8% | -15.9% |
| -4.5% | -21.1% | -18.1% | -15.6% | -13.3% | -11.2% |
| 0.5% | -16.9% | -13.8% | -11.1% | -8.7% | -6.6% |
| 5.5% | -12.8% | -9.6% | -6.7% | -4.2% | -1.9% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
60-40.00%Social Signal Score
Mentions (6)
- Newsprnewswire.com·6d ago·Negative
Knowles Expands RF Signal Chain Offering with New A-Series Attenuators New compact surface mount attenuators advance Knowles' strategy to provide customers with a more complete RF solution while delivering rugged, reliable performance from DC to 20 GHz. ITASCA, Ill.
View source ↗ - Newsbusinesswire.com·7d ago·Neutral
Knowles to Release Third Quarter 2026 Financial Results on October 22, 2026 ITASCA, Ill.--(BUSINESS WIRE)--Knowles Corporation (NYSE: KN) a leading manufacturer of specialty electronic components, including high performance capacitors, radio frequency ("RF") filters, advanced medtech microphones, and balanced armature speakers, today announced the date for the release of its third quarter 2026 financial results. Third Quarter 2026 Conference Call and Webcast Knowles will issue its third quarter …
View source ↗ - Newsdefenseworld.net·38d ago·Neutral
Knowles Targets 30% Margins as Specialty Components Drive Growth Knowles (NYSE: KN) has reshaped its portfolio around specialty electronic components for medical technology, defense and industrial markets, Chief Executive Officer Jeff Niew said during an investor presentation. The company has divested lower-margin, more commoditized operations and is emphasizing customized products, margin expansion and cash generation. Niew said Knowles generated just under $600 million in 2025
View source ↗ - Newsmarketbeat.com·40d ago·Neutral
Knowles Targets 30% Margins as Specialty Components Drive Growth Knowles NYSE: KN has reshaped its portfolio around specialty electronic components for medical technology, defense and industrial markets, Chief Executive Officer Jeff Niew said during an investor presentation. The company has divested lower-margin, more commoditized operations and is emphasizing customized products, margin expansion and cash generation.
View source ↗ - Newszacks.com·52d ago·Neutral
Knowles (KN) Is Up 6.81% in One Week: What You Should Know Does Knowles (KN) have what it takes to be a top stock pick for momentum investors? Let's find out.
View source ↗ - Newsprnewswire.com·55d ago·Neutral
Elucent Medical Selects Knowles Corporation to Manufacture Advanced Surgical Guidance Device Elucent chooses Knowles for micro molding capabilities, design-for-manufacturability expertise, and vertically integrated assembly to accelerate production of their critical surgical guidance device. ITASCA, Ill.
View source ↗
Earnings
Thu, Oct 22(in 2 weeks)
Consensus estimate $0.36 per share
Typical surprise +0.0% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Jul 23$0.33 vs $0.30beat
- Thu, Apr 23$0.27 vs $0.23beat
- Thu, Feb 5$0.36 vs $0.35beat
- Thu, Oct 23$0.33 vs $0.35miss
- Thu, Jul 24$0.02 vs $0.17miss
- Thu, Apr 24$0.18 vs $0.18beat
Estimates and results for KN via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by KN officers and directors.
- Bought
- —
- Sold
- $24.4m
0 trades
36 trades
- Shavers Cheryl Lsold
- Shavers Cheryl Lsold
- Niew Jeffreysold
- Niew Jeffreysold
- Anderson John S.sold
- Niew Jeffreysold
- Anderson John S.sold
- Cabrera Raymond D.sold
64 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- David Alfred Perduesenate · disclosed Feb 4, 2019 (27d later)Sell$1,001 - $15,000
- David Alfred Perduesenate · disclosed Feb 4, 2019 (32d later)Sell$1,001 - $15,000
- David Alfred Perduesenate · disclosed Feb 4, 2019 (28d later)Sell$1,001 - $15,000
- David Alfred Perduesenate · disclosed Jan 9, 2019 (27d later)Sell$1,001 - $15,000
- David Alfred Perduesenate · disclosed Jan 9, 2019 (22d later)Sell$1,001 - $15,000
- David Alfred Perduesenate · disclosed Dec 6, 2018 (24d later)Sell$1,001 - $15,000
- David Alfred Perduesenate · disclosed Dec 6, 2018 (23d later)Sell$1,001 - $15,000
- David Alfred Perduesenate · disclosed Aug 1, 2018 (7d later)Sell$1,001 - $15,000
- David Alfred Perduesenate · disclosed Aug 1, 2018 (7d later)Sell$1,001 - $15,000
- David Alfred Perduesenate · disclosed May 4, 2018 (842d later)Buy$1,001 - $15,000
- David Alfred Perduesenate · disclosed May 4, 2018 (812d later)Buy$1,001 - $15,000
- David Alfred Perduesenate · disclosed Mar 5, 2018 (21d later)Sell$1,001 - $15,000
- David Alfred Perduesenate · disclosed Mar 5, 2018 (19d later)Sell$1,001 - $15,000
- David Alfred Perduesenate · disclosed Mar 5, 2018 (17d later)Sell$1,001 - $15,000
- David Alfred Perduesenate · disclosed Mar 5, 2018 (11d later)Sell$1,001 - $15,000
- David Alfred Perduesenate · disclosed Aug 7, 2017 (542d later)Buy$1,001 - $15,000
- David Alfred Perduesenate · disclosed Sep 1, 2016 (503d later)Buy$1,001 - $15,000
- David Alfred Perduesenate · disclosed Sep 1, 2016 (602d later)Buy$1,001 - $15,000
- David Alfred Perduesenate · disclosed Sep 1, 2016 (589d later)Buy$1,001 - $15,000
- David Alfred Perduesenate · disclosed Sep 1, 2016 (583d later)Buy$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.